FDA approves Lilly’s migraine drug as first ever cluster headache treatment
By Michael Erman NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality...
Read MoreJun 4, 2019
By Michael Erman NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality...
Read MoreJun 4, 2019
By Sarah N. Lynch WASHINGTON (Reuters) – A top U.S. Senator signaled some support on Tuesday...
Read MoreJun 4, 2019
By Ankur Banerjee Spending time in the sun without protection increases the risk of melanoma, but the potentially deadly skin cancer can occur even on sites with minimal sun exposure, doctors warn. Melanoma accounts for only...
Read MoreJun 4, 2019
By Linda Carroll Even as a shortage of U.S. workers who care for the elderly and disabled grows, proposed limits on immigration may worsen the situation, researchers say. As of 2017, immigrants accounted for more than 18% of...
Read MoreJun 4, 2019
KARLSRUHE, Germany (Reuters) – Germany’s highest civil court on Tuesday rejected French drugmaker Sanofi’s bid to fend off a legal challenge by U.S. rival Amgen against Sanofi’s cholesterol drug Praluent....
Read MoreJun 4, 2019
By Lisa Rapaport (Reuters Health) – Death rates from falls are rising among elderly Americans – and climbing fastest among seniors in their 90s, a U.S. study suggests. Among all adults 75 and older, mortality from...
Read MoreJun 4, 2019
FRANKFURT (Reuters) – German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm’s experimental protein drugs and crop protection technology in a deal worth up to $750...
Read MoreJun 4, 2019
KINSHASA (Reuters) – The number of cases of Ebola in eastern Congo has passed 2,000, government figures showed late on Monday, as the rate of new cases tripled and containment efforts faltered in the remote, unstable...
Read MoreJun 4, 2019
By Pascale Denis and Dominique Vidalon PARIS (Reuters) – Europe’s spirits makers...
Read MoreJun 4, 2019
SYDNEY (Reuters) – Lawyers of an Australian gardener on Tuesday said they had filed a...
Read MoreJun 4, 2019
BEIJING (Reuters) – China aims to increase local production of baby formula so that more...
Read MoreJun 4, 2019
NEW DELHI (Reuters) – The deadly brain-damaging Nipah virus has resurfaced in the southern...
Read MoreJun 3, 2019
By Ana Mano SAO PAULO (Reuters) – Brazil has temporarily halted beef exports to China...
Read MoreJun 3, 2019
By Lisa Rapaport Poor people with opioid use disorders may struggle to find doctors to prescribe the anti-addiction drug buprenorphine in U.S. states with the highest overdose death rates, a new study suggests. In 2018,...
Read MoreJun 3, 2019
(Reuters) – The United States recorded 41 new measles cases last week, bringing the...
Read MoreJun 3, 2019
By Lisa Rapaport Babies who are born too soon may be more likely to develop heart disease as adults than full-term infants, a new study suggests. Adults who were born before 37 weeks gestation were 53 percent more likely to...
Read MoreJun 3, 2019
(Reuters) – The U.S. Food and Drug Administration said...
Read MoreJun 3, 2019
By Linda Carroll (Reuters Health) – Patients selected to participate in studies of cancer drugs tend to be younger than most people with the disease in the general population, researchers say. In one recent study, in fact,...
Read MoreJun 3, 2019
By Lisa Rapaport People who have mild traumatic brain injuries may be more likely to have lasting functional deficits that get in the way of daily activities than patients who experience other types of injuries, a U.S. study...
Read MoreJun 3, 2019
By Tamara Mathias (Reuters) – An experimental drug developed by Seattle Genetics Inc and...
Read More